Potential application of the consistency approach for vaccine potency testing.
The Consistency Approach offers the possibility of reducing the number of animals used for a potency test. However, it is critical to assess the effect that such reduction may have on assay performance. Consistency of production, sometimes referred to as consistency of manufacture or manufacturing, is an old concept implicit in regulation, which aims to ensure the uninterrupted release of safe and effective products. Consistency of manufacture can be described in terms of process capability, or the ability of a process to produce output within specification limits. For example, the standard method for potency testing of inactivated rabies vaccines is a multiple-dilution vaccination challenge test in mice that gives a quantitative, although highly variable estimate. On the other hand, a single-dilution test that does not give a quantitative estimate, but rather shows if the vaccine meets the specification has been proposed. This simplified test can lead to a considerable reduction in the number of animals used. However, traditional indices of process capability assume that the output population (potency values) is normally distributed, which clearly is not the case for the simplified approach. Appropriate computation of capability indices for the latter case will require special statistical considerations.
Center for Biologics Evaluation and Research, USFDA, Rockville, MD 20852, USA. juan.arciniega@fda.hhs.gov
J
J
Arciniega
L A
LA
Sirota
D000826:Animal Testing Alternatives / Q000379:methods / Q000592:standards; D000818:Animals; D051379:Mice; D011786:Quality Control; D015203:Reproducibility of Results; D014611:Vaccination / Q000379:methods* / Q000592:standards / Q000662:veterinary*; D014612:Vaccines / Q000276:immunology* / Q000592:standards
D014612:Vaccines